Ignite Creation Date:
2025-12-24 @ 4:05 PM
Ignite Modification Date:
2025-12-29 @ 9:54 PM
Study NCT ID:
NCT05814666
Status:
RECRUITING
Last Update Posted:
2024-12-31
First Post:
2023-03-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC
Sponsor:
Flamingo Therapeutics NV
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
FLM-6774-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None